No bio available.

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    LOXO/ Eli Lilly
    Date added: 
    10/02/2021
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Blueprint Medicines
    Date added: 
    10/02/2021
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Novartis
    Date added: 
    10/02/2021
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Relay Therapeutics
    Date added: 
    10/02/2021
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Bayer
    Date added: 
    10/02/2021
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Amgen
    Date added: 
    10/02/2021
Return to 2022 Precision Oncology Summit: Personalizing Treatment to Improve Patient Outcomes